GlassScriptPhysician profile
Kevin K Joseph
NPI 1396369716
$1,510.15
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $884 · 2022: $626.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $300.16 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $257.42 | 2021-2022 | |
| Alkermes, INC. | $229.81 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $212.42 | 2021-2022 | |
| Abbvie INC. | $142.59 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $94.43 | 2021 | |
| Bausch Health US, LLC | $59.68 | 2022 | |
| Corium, LLC | $56.38 | 2022 | |
| Janssen Pharmaceuticals, INC | $51.80 | 2022 | |
| Ironshore Pharmaceuticals INC. | $47.00 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $38.67 | 2022 | |
| Lundbeck LLC | $19.79 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.